换一批
换一批A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy.
第一作者：
M J,Clemons
第一单位：
CRC Department of Medical Oncology and Paterson Institute for Cancer Research, Christie Hospital, Manchester; ICRF Clinical Oncology Unit, Guy's Hospital, London.
作者：
主题词
成年人(Adult);老年人(Aged);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);骨髓细胞(Bone Marrow Cells);乳腺肿瘤(Breast Neoplasms);细胞计数(Cell Count);细胞, 培养的(Cells, Cultured);趋化因子CCL3(Chemokine CCL3);趋化因子CCL4(Chemokine CCL4);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);女(雌)性(Female);氟尿嘧啶(Fluorouracil);血细胞生成(Hematopoiesis);造血干细胞(Hematopoietic Stem Cells);人类(Humans);白细胞计数(Leukocyte Count);巨噬细胞炎性蛋白质类(Macrophage Inflammatory Proteins);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);中性白细胞(Neutrophils)
PMID
9716580
发布时间
2021-02-16
- 浏览21
Blood
1532-40页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
